tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
BioCryst weakness presents ‘compelling’ buying opportunity, says RBC
PremiumThe FlyBioCryst weakness presents ‘compelling’ buying opportunity, says RBC
2d ago
BioCryst’s Strategic Acquisition of ATXS: A Catalyst for Long-Term Growth and Profitability
Premium
Ratings
BioCryst’s Strategic Acquisition of ATXS: A Catalyst for Long-Term Growth and Profitability
2d ago
BioCryst’s Strategic Acquisition of Astria Therapeutics Boosts Market Position and Financial Outlook
Premium
Ratings
BioCryst’s Strategic Acquisition of Astria Therapeutics Boosts Market Position and Financial Outlook
2d ago
Morning Movers: Albertsons gains, Goldman falls after quarterly results
PremiumThe FlyMorning Movers: Albertsons gains, Goldman falls after quarterly results
3d ago
Video: Banks, dealmakers highlight early movers
Premium
The Fly
Video: Banks, dealmakers highlight early movers
3d ago
BioCryst Announces Merger with Astria Therapeutics
Premium
Company Announcements
BioCryst Announces Merger with Astria Therapeutics
3d ago
BioCryst downgraded to In Line from Outperform at Evercore ISI
PremiumThe FlyBioCryst downgraded to In Line from Outperform at Evercore ISI
16d ago
BioCryst Sells European ORLADEYO Business for $250M
Premium
Company Announcements
BioCryst Sells European ORLADEYO Business for $250M
16d ago
BioCryst completes sale of European ORLADEYO business for $250M
Premium
The Fly
BioCryst completes sale of European ORLADEYO business for $250M
16d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100